• Skip to content
  • Skip to search

  • Behind the Science magazine
  • Company
    • Company
    • Purpose, strategy and culture
    • GSK at a glance
    • History and heritage
    • Board of Directors and Executive Committee
    • Board information
    • Governance
      • Governance
      • Committees
      • Shareholders
      • Sarbanes-Oxley Act 2002
      • Compliance
    • Policy positions
    • Codes, standards and reports
  • Innovation
    • Innovation
    • Therapeutic areas
      • Therapeutic areas
      • Respiratory, immunology and inflammation
      • Oncology
      • HIV
      • Infectious diseases
    • Our leading scientists
      • Our leading scientists
      • Dr Tony Wood
      • Dr Sabine Luik
      • Dr Hesham Ahmed Abdullah
      • Dr Kaivan Khavandi
      • Dr Christopher Austin
      • Charlotte Allerton
      • Dr Sanjay Gurunathan
    • Research and development approach
    • Pipeline
    • Tech
      • Tech
      • Post-quantum cryptography
    • Clinical trials at GSK
      • Clinical trials at GSK
      • Provision of unapproved medicines for unmet medical needs
      • Data transparency
      • Representative clinical studies
    • Partnering with GSK
      • Partnering with GSK
      • Supported studies
    • R&D locations
      • R&D locations
      • Flagship R&D centre in Cambridge, UK
  • Products
    • Products
    • Product areas
    • Products A-Z
  • Responsibility
    • Responsibility
    • Access
    • Global health and health security
      • Global health and health security
      • Global health
      • Health security
      • Using our science for global health
      • Africa Open Lab
    • Environment
      • Environment
      • Climate
      • Freshwater
      • Land
      • Oceans
      • Materials and waste
      • Health system sustainability
    • Inclusion
    • Ethical standards
      • Ethical standards
      • Working with third parties
      • Public policy and patient advocacy
      • Human rights
      • Use of animals
      • Engaging with healthcare professionals
    • Product governance
    • Grants and donations
    • Charitable investments
    • Responsibility reports
      • Responsibility reports
      • Reports archive
  • Investors
    • Investors
    • Why invest in GSK?
    • Quarterly results
    • Financial reports
      • Financial reports
      • Annual Report 2025
      • Corporate reports archive
    • Responsible business
    • Speeches and presentations
    • Science publications
    • Events calendar
    • Dividend and share price
      • Dividend and share price
      • GSK share price
      • Share price calculators (GBp/USD)
      • Dividend calculators (GBp/USD)
      • Dividend calendar
    • Analyst consensus
    • Stock exchange announcements
      • Stock exchange announcements
      • London (RNS)
      • London (RNS) inside information
      • New York (SEC)
      • Sign up for announcements
    • Shareholder information
      • Shareholder information
      • Manage your shares
      • Annual General Meeting
      • General Meeting
      • Annual Governance Meeting
      • Corporate sponsored nominee service
      • Our ADR programme
      • Asset reunification - Georgeson
      • Share scam alert
      • Privacy notice for ordinary shareholders
      • FAQs
    • Corporate actions
      • Corporate actions
      • Consumer Healthcare Demerger
      • Consumer Healthcare Joint Venture
      • Agreement to acquire TESARO
    • Debt investors
    • Investor contacts
  • Media
    • Media
    • Press releases
    • Media contacts
    • Media statements
    • Media library
    • Our social media
    • Podcasts
    • RSS feeds
  • Careers
    • Careers
    • Search jobs
    • Featured careers
      • Featured careers
      • A career in data
    • Life at GSK
    • Outstanding people
      • Outstanding people
      • Great place to work
      • Meet our veterans
      • Working together
      • My GSK story
      • Innovating together
    • Experienced professionals
      • Experienced professionals
      • Business operations
      • Engineering at GSK
      • Global supply chain
      • Sales and marketing
      • Research and development
        • Research and development
        • Chemical Manufacturing and Controls (CMC), Medicine Development and Supply (MDS)
        • Genomic sciences
      • Technology
    • Early careers
      • Early careers
      • Application process
      • Apprentice programmes
      • Internships and placements
      • Graduate programme
        • Graduate programme
        • Business operations
        • Engineering
        • Manufacturing & supply
        • Commercial
        • Research & development
        • Manufacturing sciences & technology
      • Post graduate opportunities
      • Frequently asked questions
    • Veterans
    • Our global and regional hubs
    • How we hire
      • How we hire
      • Fraudulent internet recruitment activities
      • Frequently asked questions
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
Change locationMenu

  • Global
  • Change location
  • Dark mode

    Switch to dark mode to head towards a more sustainable world together. More info

  • Healthcare professionals Healthcare professionals
  • Contact us Contact us
GSK Homepage
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
  1. Home
  2. Search

Search

Filters

Format

219 results for "antiviral"

  • PDF - 127.4KBMedia
    Gsk Viiv Healthcare Ir Call 30 April 2019

    Gsk Viiv Healthcare Ir Call 30 April 2019

    First published: 26 March 2025

  • PDF - 5.6MBMedia
    Office Of Health Economics The Overlooked Burden Of Shingles In England’S Population 80 And Over

    Office Of Health Economics The Overlooked Burden Of Shingles In England’S Population 80 And Over

    First published: 06 May 2026

  • PDF - 3.9MBMedia
    Corporate Responsibility Report 2009

    Corporate Responsibility Report 2009

    First published: 17 March 2025

  • PDF - 3.9MBMedia
    Cr Report 2009

    Cr Report 2009

    First published: 01 June 2022

  • PDF - 695.6KBMedia
    Q1 2026 pipeline assets and clinical trials report

    Q1 2026 pipeline assets and clinical trials report

    First published: 29 April 2026

  • PDF - 740.8KBMedia
    Q2 2026 pipeline assets and clinical trials report

    Q2 2026 pipeline assets and clinical trials report

    First published: 28 July 2026

  • PDF - 174.6KBMedia
    Q1 2025 results transcript

    Q1 2025 results transcript

    First published: 19 May 2025

  • PDF - 769.5KBMedia
    FY 2025 results slides

    FY 2025 results slides

    First published: 05 February 2026

  • PDF - 733.6KBMedia
    FY 2025 pipeline assets and clinical trials report

    FY 2025 pipeline assets and clinical trials report

    First published: 04 February 2026

  • PDF - 5.5MBMedia
    Corporate Responsibility Report 2013

    Corporate Responsibility Report 2013

    First published: 17 March 2025

  1. previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. 8
  10. 9
  11. 10
  12. next
Gsk Logo

This is our global website, intended for visitors seeking information on GSK's worldwide business.  Our market sites can be reached by visiting our location selector.  

 

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

GSK plc. Registered in England and Wales No. 3888792.

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

> Modern Slavery Act Statement 2025 (PDF - 187.7KB)

GSK websites
  • Locations selector
  • Social media directory
  • GSKPro for healthcare professionals
  • GSK study register
  • Supplier website
  • ViiV Healthcare
Quick links
  • Behind the Science magazine
  • Company
  • Innovation
  • Products
  • Responsibility
  • Investors
  • Media
  • Careers
Get in touch
  • Contact us
  • Partnerships
  • Report a possible side effect
  • GSK Speak up
Follow us on:
  • Accessibility
  • Digital sustainability
  • Terms of use
  • Cookie policy
  • Privacy notice
  • Sitemap